SeaBeLife
Business Services · France · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Place Georges Teissier, Roscoff, Brittan...Phone Number
+33 298292348Website
www.seabelife.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About SeaBeLife
SeaBeLife is a biotechnology company that is currently developing families of patented candidate molecules designed to block regulated necrosis (that is, regulated cell death). SeaBeLife technology has been demonstrated in vitro and in several proofs-of-concept in vivo, to be able to simultaneously block two forms of regulated cell death and thus to protect organs under attack from disease.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SeaBeLife your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when SeaBeLife launches new products
SeaBeLife, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at SeaBeLife
Funding: Get notified immidiatlly once SeaBeLife has new funding data
Check out if SeaBeLife is spiking on competitors!
Earning: See what the market has to say on SeaBeLife recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if SeaBeLife had a recent Job posting/layoffs
Check if SeaBeLife has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at SeaBeLife
Find 2 more new buyers
Company Profile Activity
Activity Insights
SeaBeLife is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
SeaBeLife is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about SeaBeLife.
SeaBeLife financials insights
Gather financial insights about SeaBeLife, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Unspecified
$1.5M
2023
Angel/Seed
$1.3M
2025
Other Financing Round
$2.3M
SeaBeLife Tech Stack
A closer look at the technologies used by SeaBeLife
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Person-Based
Funding
Funding
SeaBeLife News & Media
Biotech SeaBeLife awarded €1.5M to combat visual degeneration
SeaBeLife, a biotech company developing drugs intended to block cellular necrosis, has been awarded over €1.5M for its SeaBeEYE project at the i-Nov 2024 innovation competition.Funded by the French go...SeaBeLife Raises €1.2M in Seed Funding
SeaBeLife, a Roscoff, France-based biotech company developing drug candidates intended to block cell necrosis, raised €1.2M in additional Seed funding. The round, which brough the total amount to €1.6M, was led by XLife fund and business angel networks including Breizh Angels, Angels Santé, WeLike and BAdGE. The company intends to use the funds to finance […] The post SeaBeLife Raises €1.2M in Seed Funding appeared first on FinSMEs.SeaBeLife secures close to EUR1.4m in deep tech financing from Bpifrance
SeaBeLife secures close to EUR1.4m in deep tech financing from Bpifrance Submitted 14/03/2022 - 9:46am SeaBeLife, a biotech company developing drug candidates intended to block cell necrosis, has received EUR1.37 million (USD1.49 million) in financing from Bpifrance. This financing, which has been granted in connection with the French government’s ‘Deeptech Plan’, will contribute to research into first-in-class drug candidates for the treatment of acute liver, kidney, heart and brain disease. ThStopping destructive cell death in its tracks, SeaBeLife secures €1.37 million
Brittany-based biotech startup SeaBeLife has been awarded €1.37 million from Bpifrance, as part of the French government’s deeptech plan initiative. Niche to say the least, but if successful, SeaBeLif...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding SeaBeLife
Sign Up For FreeTo access detailed company insights
SeaBeLife is a biotechnology company that is currently developing families of patented candidate molecules designed to block regulated necrosis (that is, regulated cell death). SeaBeLife technology has been demonstrated in vitro and in several proofs-of-concept in vivo, to be able to simultaneously block two forms of regulated cell death and thus t... Read More
